RUNX2 and ocular melanoma: Moreover, in hBMSCs treated with OM and RBC‐apoVs, the mRNA expression level of the osteogenic markers ALP, RUNX2, COL1A1 and BSP increased significantly after 5 days and that of ALP, RUNX2, OCN and OPN after 10 days (Figure 4G).